CEPHALON INC
10-Q, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: CEPHALON INC, 10-Q, 2000-08-14
Next: NAB ASSET CORP, 10-Q, 2000-08-14



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Cephalon,
Inc.'s Form 10-Q for the quarter ended June 30, 2000 and is qualified in its
entirety by reference to such financial statements.
</LEGEND>
<CIK> 0000873364
<NAME> CEPHALON, INC.

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      29,010,000
<SECURITIES>                               121,377,000
<RECEIVABLES>                               11,017,000
<ALLOWANCES>                                         0
<INVENTORY>                                 14,465,000
<CURRENT-ASSETS>                           176,895,000
<PP&E>                                      40,369,000
<DEPRECIATION>                              16,030,000
<TOTAL-ASSETS>                             203,687,000
<CURRENT-LIABILITIES>                       29,330,000
<BONDS>                                     13,486,000
                                0
                                     25,000
<COMMON>                                       348,000
<OTHER-SE>                                 160,300,000
<TOTAL-LIABILITY-AND-EQUITY>               203,687,000
<SALES>                                     28,750,000
<TOTAL-REVENUES>                            38,006,000
<CGS>                                        5,074,000
<TOTAL-COSTS>                                5,074,000
<OTHER-EXPENSES>                            27,377,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           2,949,000
<INCOME-PRETAX>                           (16,400,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (16,400,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (20,931,000)
<EPS-BASIC>                                     (0.63)
<EPS-DILUTED>                                   (0.63)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission